---
theme: academic
layout: cover
class: text-white
coverAuthor: beau hilton
coverAuthorUrl: https://www.beauhilton.com
coverDate: "2025-01-23"
themeConfig:
  paginationX: r
  paginationY: t
  paginationPagesDisabled: [1]
title: Cold Agglutinin Disease
info: |
  # Cold Agglutinin Disease
  Case Conference 2025-01-23, [Beau Hilton](https://www.beauhilton.com)
---

# Cold Agglutinin Disease

---

layout: figure
figureFootnoteNumber: 1
figureUrl: ./images/mxn.png

---

# 500 Million BCE

---

# Case presentation

72F, p/w hgb 3.8. A little tired.

<v-clicks>

Some discoloration of fingers, she says it's worse (and painful) when it's cold.

No notable icterus.

Elevated indirect bili.

LDH elevated. Hapto undetectable.

Retic elevated.

+RBC clumping on smear. Other cells normal in morphology and number.

DAT: IgG+ (weak), C3+

Cold agglutinin titre: way >64

</v-clicks>

---

layout: figure
figureFootnoteNumber: 1
figureUrl: ./images/mxn.png

---

# Pathophysiology

Berentsen,
_Frontiers in Immunology_,
2020

---

# Confirming the diagnosis

<v-clicks>

- flow cytometry
- SPEP, SFLC (usu IgM kappa)
- maximal thermal amplitude (>28C)
- cold-temperature titre (>=64 @ 4C)
- BMBx (sometimes)

</v-clicks>

---

# Differential diagnosis

<v-clicks>

- no B symptoms (may be difficult to separate from infx)
- no extramedullary disease (may push you toward MZL)
- CD5- (>50% CAD -ve for CD5), CD10- B cells: MZL vs IgM LPL (Waldenstrom)
- MYD88 L265P -ve (usu + in LPL)
- certain clusters of genomic and cytogenetic changes, e.g. KMT2D variant (69%) complete or partial gain of chromosome 3 (93%)
- WHO 2022: CAD is now a distinct lymphoid neoplasm (CAD-associated LPD) (hopefully, more diagnostic consensus will follow)

</v-clicks>

---

layout: figure
figureFootnoteNumber: 1
figureUrl: ./images/dx-algo.png

---

# Diagnostic algorithm

Berentsen, Fattizzo, Barcellini,
_Frontiers in Immunology_,
2023

---

# Case presentation

<v-clicks>

- 2010: p/w hemolytic anemia, eventually found to have cold agglutinin disease
- 2010 - 2015: rituximab, multiple cycles
- 2016: rituximab + fludarabine
- 2018: rituximab + bortezomib
- 2019: rituximab + bendamustine
- 2022: sutimlimab recommended

</v-clicks>

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/de-urinis.png

---

# A jaunt through history

## 1200s

Johannes Actuarius, Constantinople court physician, publishes _De Urinis_, which notes: "Yea indeed an extremely black urine... signifies extreme chilliness."

<v-clicks>

(syphilis causes paroxysmal cold hemoglobinuria, so used to be much more common)

(but watch out for a resurgence - syphilis cases went up 80%, to 207,000 in 2022)

</v-clicks>

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/poor-pup.png

---

# A jaunt through history

## 1800s

Trypanosomiasis (N'gana, sleeping sickness) is found to cause deep anemias, partially via hemolysis.

https://vetclinpathimages.com/2018/04/27/trypanosoma/

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/trypanosomes-bovine.jpg

---

# A jaunt through history

## 1898

Mssrs. Kanthack, Durham, and Blandford describe agglutination
in red blood cells of animals infected with trypanosomes.

"Instead of forming rouleaux,
the red corpuscles tend to clump into masses and to lose their outlines,
especially when the anaemia is pronounced (rabbit, ass, and horse).
The serum of such blood, when mixed with normal blood of the same species of animal,
causes the red corpuscles to clump together also."

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/karl.jpg

---

# A jaunt through history

## 1903

Karl Landsteiner publishes "About Relationships Between the Blood Serum and the Body Cells"
(_Über Beziehungen zwischen dem Blutserum und den Körperzellen_),
which contains a description of blood agglutination at cold temperatures (thermal amplitude 0-5C).

He's the guy who discovered blood types,
under the term "iso-agglutination,"
and won the Nobel Prize in Medicine for this in 1930.

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/mycoplasma.jpg

---

# A jaunt through history

## 1918

Clough and Richter publish "A study of an autoagglutinin occurring in a human serum,"
first definite cases of cold agglutination in humans,
describing the relationship between agglutination, hemolysis, and pneumonia.

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/churchill.jpg

---

# A jaunt through history

## 1937

McCombs and McElroy note that the huge increase in surgical transfusions
since Landsteiner's discovery has revealed a number of cases of cold agglutination
found in the blood bank (thermal amplitude 0-25 C), confusing technicians nation-wide.

(And occasionally leading to death)

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/coat.png

---

# A jaunt through history

## 1946

Lubinski and Goldbloom collect and describe 7 cases of cold agglutination with a thermal amplitude of 0-37C,
all associated with hemolytic anemia (5 primary cases, 1 sepsis, 1 syphilis).

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/electro.png

---

# A jaunt through history

## 1957

Christenson et al perform the first isolation of a monoclonal protein, a cold agglutinin.
One of the pts also has a cryoglobulin.

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/olesen.png

---

# A jaunt through history

## 1964

Olesen publishes the first paper with a successful drug treatment for CAD,
choosing chlorambucil based on the then-recent success of this drug in Waldenstrom macroglobulinemia.
Follow-up in 1970 with 4 pts has similar results.

(One pt got cyclophosphamide for 4mo, switched to chlorambucil later on d/t drAE).

---

# A jaunt through history

## 1997

Rituximab comes to market.

## 1998

Lee and Kueck try rituximab (375 x4) in a pt w CAD, and it works.

## 2001

Berentsen et al report on a small prospective ritux study: 1 CR, 3 PR, 2 no response.

## 2006, 2013

Berentsen et al retrospective study: ritux-based regimens RR 67-83%.

---

# A jaunt through history

## 2017

Berentsen et al, prospective study using BR: 71% RR, 40% CR, 31% PR. 50% RR in the retreatment setting. TTR 2mo. 77% response rate at 5y. Median DOR >88mo.

## 2018

Rossi et al report on 2L bortezomib (GIMEMA) (single cycle): 32% RR, median DOR 16mo.

## 2020, 2021

Case reports on CAS d/t pembro (Atiq 2020) and atezo (Acikgoz 2021).

---

layout: figure-side
figureFootnoteNumber: 1
figureUrl: ./images/cadenza.png

---

# A jaunt through history

## 2021

Roth et al report (NEJM) on sutimlimab monotherapy (CARDINAL) (nonrandomized)

## 2022

Roth et al report (Blood) on sutimlimab monotherapy (CADENZA) (phase III placebo-controlled RCT)

---

layout: figure
figureFootnoteNumber: 1
figureUrl: ./images/teae-sutimlimab.png

---

# A jaunt through history

## Blood 2022, Roth et al

---

layout: figure
figureFootnoteNumber: 1
figureUrl: ./images/tx-data.png

---

# Tx options overview

Berentsen, Fattizzo, Barcellini, _Frontiers in Immunology_ 2023

---

layout: figure
figureFootnoteNumber: 1
figureUrl: ./images/tx-algo.png

---

# Tx sequencing overview

Berentsen, Fattizzo, Barcellini, _Frontiers in Immunology_ 2023

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Acikgoz, O., Bayramgil, A., Cavusoglu, G., &amp; Sadri, S. (2021). Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease. <i>Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners</i>, <i>27</i>(8), 2066–2068. <a href="https://doi.org/10.1177/10781552211033009">https://doi.org/10.1177/10781552211033009</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1177%2F10781552211033009&amp;rft_id=info%3Apmid%2F34282980&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rare%20side%20effect%20caused%20by%20atezolizumab%2C%20an%20immune%20checkpoint%20inhibitor%3A%20Cold%20agglutinin%20disease&amp;rft.jtitle=Journal%20of%20Oncology%20Pharmacy%20Practice%3A%20Official%20Publication%20of%20the%20International%20Society%20of%20Oncology%20Pharmacy%20Practitioners&amp;rft.stitle=J%20Oncol%20Pharm%20Pract&amp;rft.volume=27&amp;rft.issue=8&amp;rft.aufirst=Ozgur&amp;rft.aulast=Acikgoz&amp;rft.au=Ozgur%20Acikgoz&amp;rft.au=Ayberk%20Bayramgil&amp;rft.au=Gunes%20Cavusoglu&amp;rft.au=Sevil%20Sadri&amp;rft.date=2021-12&amp;rft.pages=2066-2068&amp;rft.spage=2066&amp;rft.epage=2068&amp;rft.issn=1477-092X&amp;rft.language=eng"></span>
  <div class="csl-entry">Atiq, O., Atiq, S. O., Atiq, Z. O., Patel, V., Atiq, M. O., &amp; Atiq, O. T. (2020). Pembrolizumab-Induced Cold Agglutinin Disease. <i>The American Journal of Case Reports</i>, <i>21</i>, e924283. <a href="https://doi.org/10.12659/AJCR.924283">https://doi.org/10.12659/AJCR.924283</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.12659%2FAJCR.924283&amp;rft_id=info%3Apmid%2F32887867&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pembrolizumab-Induced%20Cold%20Agglutinin%20Disease&amp;rft.jtitle=The%20American%20Journal%20of%20Case%20Reports&amp;rft.stitle=Am%20J%20Case%20Rep&amp;rft.volume=21&amp;rft.aufirst=Osman&amp;rft.aulast=Atiq&amp;rft.au=Osman%20Atiq&amp;rft.au=Saad%20O.%20Atiq&amp;rft.au=Zainab%20O.%20Atiq&amp;rft.au=Vijay%20Patel&amp;rft.au=Mohammad%20O.%20Atiq&amp;rft.au=Omar%20T.%20Atiq&amp;rft.date=2020-09-05&amp;rft.pages=e924283&amp;rft.issn=1941-5923&amp;rft.language=eng"></span>
  <div class="csl-entry">Berentsen, S. (2016). Cold agglutinin disease. <i>Hematology: The American Society of Hematology Education Program</i>, <i>2016</i>(1), 226–231.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Apmid%2F27913484&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cold%20agglutinin%20disease&amp;rft.jtitle=Hematology%3A%20the%20American%20Society%20of%20Hematology%20Education%20Program&amp;rft.stitle=Hematology%20Am%20Soc%20Hematol%20Educ%20Program&amp;rft.volume=2016&amp;rft.issue=1&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.date=2016-12-02&amp;rft.pages=226-231&amp;rft.spage=226&amp;rft.epage=231&amp;rft.issn=1520-4391"></span>
  <div class="csl-entry">Berentsen, S. (2020). New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. <i>Frontiers in Immunology</i>, <i>11</i>, 590. <a href="https://doi.org/10.3389/fimmu.2020.00590">https://doi.org/10.3389/fimmu.2020.00590</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.3389%2Ffimmu.2020.00590&amp;rft_id=info%3Apmid%2F32318071&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New%20Insights%20in%20the%20Pathogenesis%20and%20Therapy%20of%20Cold%20Agglutinin-Mediated%20Autoimmune%20Hemolytic%20Anemia&amp;rft.jtitle=Frontiers%20in%20Immunology&amp;rft.stitle=Front%20Immunol&amp;rft.volume=11&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.date=2020&amp;rft.pages=590&amp;rft.issn=1664-3224&amp;rft.language=eng"></span>
  <div class="csl-entry">Berentsen, S. (2021). How I treat cold agglutinin disease. <i>Blood</i>, <i>137</i>(10), 1295–1303. <a href="https://doi.org/10.1182/blood.2019003809">https://doi.org/10.1182/blood.2019003809</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.2019003809&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=How%20I%20treat%20cold%20agglutinin%20disease&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=137&amp;rft.issue=10&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.date=2021-03-11&amp;rft.pages=1295-1303&amp;rft.spage=1295&amp;rft.epage=1303&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Berentsen, S., Barcellini, W., D’Sa, S., &amp; Jilma, B. (2022). Sutimlimab for treatment of cold agglutinin disease: Why, how and for whom? <i>Immunotherapy</i>, <i>14</i>(15), 1191–1204. <a href="https://doi.org/10.2217/imt-2022-0085">https://doi.org/10.2217/imt-2022-0085</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.2217%2Fimt-2022-0085&amp;rft_id=info%3Apmid%2F35946351&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sutimlimab%20for%20treatment%20of%20cold%20agglutinin%20disease%3A%20why%2C%20how%20and%20for%20whom%3F&amp;rft.jtitle=Immunotherapy&amp;rft.stitle=Immunotherapy&amp;rft.volume=14&amp;rft.issue=15&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Shirley%20D'Sa&amp;rft.au=Bernd%20Jilma&amp;rft.date=2022-10&amp;rft.pages=1191-1204&amp;rft.spage=1191&amp;rft.epage=1204&amp;rft.issn=1750-7448&amp;rft.language=eng"></span>
  <div class="csl-entry">Berentsen, S., Barcellini, W., D’Sa, S., Randen, U., Tvedt, T. H. A., Fattizzo, B., Haukås, E., Kell, M., Brudevold, R., Dahm, A. E. A., Dalgaard, J., Frøen, H., Hallstensen, R. F., Jæger, P. H., Hjorth-Hansen, H., Małecka, A., Oksman, M., Rolke, J., Sekhar, M., … Tjønnfjord, G. E. (2020). Cold agglutinin disease revisited: A multinational, observational study of 232 patients. <i>Blood</i>, <i>136</i>(4), 480–488. <a href="https://doi.org/10.1182/blood.2020005674">https://doi.org/10.1182/blood.2020005674</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.2020005674&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cold%20agglutinin%20disease%20revisited%3A%20a%20multinational%2C%20observational%20study%20of%20232%20patients&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=136&amp;rft.issue=4&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Shirley%20D%E2%80%99Sa&amp;rft.au=Ulla%20Randen&amp;rft.au=Tor%20Henrik%20Anderson%20Tvedt&amp;rft.au=Bruno%20Fattizzo&amp;rft.au=Einar%20Hauk%C3%A5s&amp;rft.au=Megan%20Kell&amp;rft.au=Robert%20Brudevold&amp;rft.au=Anders%20E.%20A.%20Dahm&amp;rft.au=Jakob%20Dalgaard&amp;rft.au=Hege%20Fr%C3%B8en&amp;rft.au=Randi%20Fykse%20Hallstensen&amp;rft.au=Pernille%20H.%20J%C3%A6ger&amp;rft.au=Henrik%20Hjorth-Hansen&amp;rft.au=Agnieszka%20Ma%C5%82ecka&amp;rft.au=Markku%20Oksman&amp;rft.au=J%C3%BCrgen%20Rolke&amp;rft.au=Mallika%20Sekhar&amp;rft.au=Jon%20Hjalmar%20S%C3%B8rb%C3%B8&amp;rft.au=Eirik%20Tj%C3%B8nnfjord&amp;rft.au=Galina%20Tsykunova&amp;rft.au=Geir%20E.%20Tj%C3%B8nnfjord&amp;rft.date=2020-07-23&amp;rft.pages=480-488&amp;rft.spage=480&amp;rft.epage=488&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Berentsen, S., Fattizzo, B., &amp; Barcellini, W. (2023). The choice of new treatments in autoimmune hemolytic anemia: How to pick from the basket? <i>Frontiers in Immunology</i>, <i>14</i>, 1180509. <a href="https://doi.org/10.3389/fimmu.2023.1180509">https://doi.org/10.3389/fimmu.2023.1180509</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.3389%2Ffimmu.2023.1180509&amp;rft_id=info%3Apmid%2F37168855&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The%20choice%20of%20new%20treatments%20in%20autoimmune%20hemolytic%20anemia%3A%20how%20to%20pick%20from%20the%20basket%3F&amp;rft.jtitle=Frontiers%20in%20Immunology&amp;rft.stitle=Front%20Immunol&amp;rft.volume=14&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.au=Bruno%20Fattizzo&amp;rft.au=Wilma%20Barcellini&amp;rft.date=2023-04-24&amp;rft.pages=1180509&amp;rft.issn=1664-3224"></span>
  <div class="csl-entry">Berentsen, S., Tjønnfjord, G. E., Brudevold, R., Gjertsen, B. T., Langholm, R., Løkkevik, E., Sørbø, J. H., &amp; Ulvestad, E. (2001). Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. <i>British Journal of Haematology</i>, <i>115</i>(1), 79–83. <a href="https://doi.org/10.1046/j.1365-2141.2001.03078.x">https://doi.org/10.1046/j.1365-2141.2001.03078.x</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2141.2001.03078.x&amp;rft_id=info%3Apmid%2F11722415&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Favourable%20response%20to%20therapy%20with%20the%20anti-CD20%20monoclonal%20antibody%20rituximab%20in%20primary%20chronic%20cold%20agglutinin%20disease&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.stitle=Br%20J%20Haematol&amp;rft.volume=115&amp;rft.issue=1&amp;rft.aufirst=S.&amp;rft.aulast=Berentsen&amp;rft.au=S.%20Berentsen&amp;rft.au=G.%20E.%20Tj%C3%B8nnfjord&amp;rft.au=R.%20Brudevold&amp;rft.au=B.%20T.%20Gjertsen&amp;rft.au=R.%20Langholm&amp;rft.au=E.%20L%C3%B8kkevik&amp;rft.au=J.%20H.%20S%C3%B8rb%C3%B8&amp;rft.au=E.%20Ulvestad&amp;rft.date=2001-10&amp;rft.pages=79-83&amp;rft.spage=79&amp;rft.epage=83&amp;rft.issn=0007-1048&amp;rft.language=eng"></span>
  <div class="csl-entry">Berentsen, S., Ulvestad, E., Langholm, R., Beiske, K., Hjorth-Hansen, H., Ghanima, W., Sørbø, J. H., &amp; Tjønnfjord, G. E. (2006). Primary chronic cold agglutinin disease: A population based clinical study of 86 patients. <i>Haematologica</i>, <i>91</i>(4), 460–466.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Apmid%2F16585012&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20chronic%20cold%20agglutinin%20disease%3A%20a%20population%20based%20clinical%20study%20of%2086%20patients&amp;rft.jtitle=Haematologica&amp;rft.stitle=Haematologica&amp;rft.volume=91&amp;rft.issue=4&amp;rft.aufirst=Sigbj%C3%B8rn&amp;rft.aulast=Berentsen&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.au=Elling%20Ulvestad&amp;rft.au=Ruth%20Langholm&amp;rft.au=Klaus%20Beiske&amp;rft.au=Henrik%20Hjorth-Hansen&amp;rft.au=Waleed%20Ghanima&amp;rft.au=Jon%20Hjalmar%20S%C3%B8rb%C3%B8&amp;rft.au=Geir%20E.%20Tj%C3%B8nnfjord&amp;rft.date=2006-04&amp;rft.pages=460-466&amp;rft.spage=460&amp;rft.epage=466&amp;rft.issn=1592-8721&amp;rft.language=eng"></span>
</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Bhattacharyya, J., Mihara, K., Takihara, Y., &amp; Kimura, A. (2012). Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide. <i>Annals of Hematology</i>, <i>91</i>(5), 797–799. <a href="https://doi.org/10.1007/s00277-011-1322-0">https://doi.org/10.1007/s00277-011-1322-0</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1007%2Fs00277-011-1322-0&amp;rft_id=info%3Apmid%2F21901341&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Successful%20treatment%20of%20IgM-monoclonal%20gammopathy%20of%20undetermined%20significance%20associated%20with%20cryoglobulinemia%20and%20cold%20agglutinin%20disease%20with%20immunochemotherapy%20with%20rituximab%2C%20fludarabine%2C%20and%20cyclophosphamide&amp;rft.jtitle=Annals%20of%20Hematology&amp;rft.stitle=Ann%20Hematol&amp;rft.volume=91&amp;rft.issue=5&amp;rft.aufirst=Joyeeta&amp;rft.aulast=Bhattacharyya&amp;rft.au=Joyeeta%20Bhattacharyya&amp;rft.au=Keichiro%20Mihara&amp;rft.au=Yoshihiro%20Takihara&amp;rft.au=Akiro%20Kimura&amp;rft.date=2012-05&amp;rft.pages=797-799&amp;rft.spage=797&amp;rft.epage=799&amp;rft.issn=1432-0584&amp;rft.language=eng"></span>
  <div class="csl-entry">Broome, C. M. (2023). Complement-directed therapy for cold agglutinin disease: Sutimlimab. <i>Expert Review of Hematology</i>, <i>16</i>(7), 479–494. <a href="https://doi.org/10.1080/17474086.2023.2218611">https://doi.org/10.1080/17474086.2023.2218611</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1080%2F17474086.2023.2218611&amp;rft_id=info%3Apmid%2F37256550&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Complement-directed%20therapy%20for%20cold%20agglutinin%20disease%3A%20sutimlimab&amp;rft.jtitle=Expert%20Review%20of%20Hematology&amp;rft.stitle=Expert%20Rev%20Hematol&amp;rft.volume=16&amp;rft.issue=7&amp;rft.aufirst=Catherine%20M.&amp;rft.aulast=Broome&amp;rft.au=Catherine%20M.%20Broome&amp;rft.date=2023&amp;rft.pages=479-494&amp;rft.spage=479&amp;rft.epage=494&amp;rft.issn=1747-4094&amp;rft.language=eng"></span>
  <div class="csl-entry">Christenson, W. N., Dacie, J. V., Croucher, B. E. E., &amp; Charlwood, P. A. (1957). Electrophoretic Studies on Sera containing High-Titre Cold Haemagglutinins: Identification of the Antibody as the Cause of an Abnormal γ Peak. <i>British Journal of Haematology</i>, <i>3</i>(3), 262–273. <a href="https://doi.org/10.1111/j.1365-2141.1957.tb05795.x">https://doi.org/10.1111/j.1365-2141.1957.tb05795.x</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.1957.tb05795.x&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Electrophoretic%20Studies%20on%20Sera%20containing%20High-Titre%20Cold%20Haemagglutinins%3A%20Identification%20of%20the%20Antibody%20as%20the%20Cause%20of%20an%20Abnormal%20%CE%B3%20Peak&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.volume=3&amp;rft.issue=3&amp;rft.aufirst=W.%20N.&amp;rft.aulast=Christenson&amp;rft.au=W.%20N.%20Christenson&amp;rft.au=J.%20V.%20Dacie&amp;rft.au=B.%20E.%20E.%20Croucher&amp;rft.au=P.%20A.%20Charlwood&amp;rft.date=1957&amp;rft.pages=262-273&amp;rft.spage=262&amp;rft.epage=273&amp;rft.issn=1365-2141&amp;rft.language=en"></span>
  <div class="csl-entry">Clough, M. C., &amp; Richter, I. M. (1918). A study of an autoagglutinin occurring in a human serum. <i>Johns Hopkins Hosp Bull</i>, <i>29</i>, 86.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A%20study%20of%20an%20autoagglutinin%20occurring%20in%20a%20human%20serum&amp;rft.jtitle=Johns%20Hopkins%20Hosp%20Bull&amp;rft.volume=29&amp;rft.aufirst=Mildred%20C&amp;rft.aulast=Clough&amp;rft.au=Mildred%20C%20Clough&amp;rft.au=Ina%20M%20Richter&amp;rft.date=1918&amp;rft.pages=86"></span>
  <div class="csl-entry">Cunha, B. A., &amp; Pherez, F. M. (2009). Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis. <i>Heart &amp; Lung: The Journal of Critical Care</i>, <i>38</i>(5), 444–449. <a href="https://doi.org/10.1016/j.hrtlng.2008.10.005">https://doi.org/10.1016/j.hrtlng.2008.10.005</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.hrtlng.2008.10.005&amp;rft_id=info%3Apmid%2F19755196&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mycoplasma%20pneumoniae%20community-acquired%20pneumonia%20(CAP)%20in%20the%20elderly%3A%20Diagnostic%20significance%20of%20acute%20thrombocytosis&amp;rft.jtitle=Heart%20%26%20Lung%3A%20The%20Journal%20of%20Critical%20Care&amp;rft.stitle=Heart%20Lung&amp;rft.volume=38&amp;rft.issue=5&amp;rft.aufirst=Burke%20A.&amp;rft.aulast=Cunha&amp;rft.au=Burke%20A.%20Cunha&amp;rft.au=Francisco%20M.%20Pherez&amp;rft.date=2009&amp;rft.pages=444-449&amp;rft.spage=444&amp;rft.epage=449&amp;rft.issn=1527-3288&amp;rft.language=eng"></span>
  <div class="csl-entry">Donath, J., &amp; Landsteiner, K. (1904). Über paroxysmale Hämoglobinurie. <i>Münchener medizinische Wochenschrift</i>, <i>51</i>, 1590–1593.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%C3%9Cber%20paroxysmale%20H%C3%A4moglobinurie&amp;rft.jtitle=M%C3%BCnchener%20medizinische%20Wochenschrift&amp;rft.stitle=M%C3%BCnch%20Med%20Wschr&amp;rft.volume=51&amp;rft.aufirst=Julius&amp;rft.aulast=Donath&amp;rft.au=Julius%20Donath&amp;rft.au=Karl%20Landsteiner&amp;rft.date=1904&amp;rft.pages=1590-1593&amp;rft.spage=1590&amp;rft.epage=1593&amp;rft.language=German"></span>
  <div class="csl-entry">Evans, R. S., Baxter, E., &amp; Gilliland, B. C. (1973). Chronic Hemolytic Anemia Due to Cold Agglutinins: A 20-Year History of Benign Gammopathy With Response to Chlorambucil. <i>Blood</i>, <i>42</i>(3), 463–470. <a href="https://doi.org/10.1182/blood.V42.3.463.463">https://doi.org/10.1182/blood.V42.3.463.463</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V42.3.463.463&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chronic%20Hemolytic%20Anemia%20Due%20to%20Cold%20Agglutinins%3A%20A%2020-Year%20History%20of%20Benign%20Gammopathy%20With%20Response%20to%20Chlorambucil&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=42&amp;rft.issue=3&amp;rft.aufirst=Robert%20S.&amp;rft.aulast=Evans&amp;rft.au=Robert%20S.%20Evans&amp;rft.au=Elizabeth%20Baxter&amp;rft.au=Bruce%20C.%20Gilliland&amp;rft.date=1973-09-01&amp;rft.pages=463-470&amp;rft.spage=463&amp;rft.epage=470&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Gelbenegger, G., Berentsen, S., &amp; Jilma, B. (2023). Monoclonal antibodies for treatment of cold agglutinin disease. <i>Expert Opinion on Biological Therapy</i>, <i>23</i>(5), 395–406. <a href="https://doi.org/10.1080/14712598.2023.2209265">https://doi.org/10.1080/14712598.2023.2209265</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1080%2F14712598.2023.2209265&amp;rft_id=info%3Apmid%2F37128907&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Monoclonal%20antibodies%20for%20treatment%20of%20cold%20agglutinin%20disease&amp;rft.jtitle=Expert%20Opinion%20on%20Biological%20Therapy&amp;rft.stitle=Expert%20Opin%20Biol%20Ther&amp;rft.volume=23&amp;rft.issue=5&amp;rft.aufirst=Georg&amp;rft.aulast=Gelbenegger&amp;rft.au=Georg%20Gelbenegger&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.au=Bernd%20Jilma&amp;rft.date=2023-05&amp;rft.pages=395-406&amp;rft.spage=395&amp;rft.epage=406&amp;rft.issn=1744-7682&amp;rft.language=eng"></span>
  <div class="csl-entry">Gertz, M. A. (2022). Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia. <i>Hematology/Oncology Clinics of North America</i>, <i>36</i>(2), 341–352. <a href="https://doi.org/10.1016/j.hoc.2021.11.001">https://doi.org/10.1016/j.hoc.2021.11.001</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.hoc.2021.11.001&amp;rft_id=info%3Apmid%2F35282954&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Updates%20on%20the%20Diagnosis%20and%20Management%20of%20Cold%20Autoimmune%20Hemolytic%20Anemia&amp;rft.jtitle=Hematology%2FOncology%20Clinics%20of%20North%20America&amp;rft.stitle=Hematol%20Oncol%20Clin%20North%20Am&amp;rft.volume=36&amp;rft.issue=2&amp;rft.aufirst=Morie%20A.&amp;rft.aulast=Gertz&amp;rft.au=Morie%20A.%20Gertz&amp;rft.date=2022-04&amp;rft.pages=341-352&amp;rft.spage=341&amp;rft.epage=352&amp;rft.issn=1558-1977&amp;rft.language=eng"></span>
  <div class="csl-entry">Hippe, E., Jensen, K. B., Olesen, H., Lind, K., &amp; Thomsen, P. E. B. (1970). Chlorambucil Treatment of Patients With Cold Agglutinin Syndrome. <i>Blood</i>, <i>35</i>(1), 68–72. <a href="https://doi.org/10.1182/blood.V35.1.68.68">https://doi.org/10.1182/blood.V35.1.68.68</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V35.1.68.68&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chlorambucil%20Treatment%20of%20Patients%20With%20Cold%20Agglutinin%20Syndrome&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=35&amp;rft.issue=1&amp;rft.aufirst=E.&amp;rft.aulast=Hippe&amp;rft.au=E.%20Hippe&amp;rft.au=K.%20B.%20Jensen&amp;rft.au=H.%20Olesen&amp;rft.au=K.%20Lind&amp;rft.au=P.%20E.%20B.%20Thomsen&amp;rft.date=1970-01-01&amp;rft.pages=68-72&amp;rft.spage=68&amp;rft.epage=72&amp;rft.issn=0006-4971"></span>

</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Horstmann, D. M., &amp; Tatlock, H. (1943). COLD AGGLUTININS: A DIAGNOSTIC AID IN CERTAIN TYPES OF PRIMARY ATYPICAL PNEUMONIA. <i>Journal of the American Medical Association</i>, <i>122</i>(6), 369–370. <a href="https://doi.org/10.1001/jama.1943.72840230003006a">https://doi.org/10.1001/jama.1943.72840230003006a</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1943.72840230003006a&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=COLD%20AGGLUTININS%3A%20A%20DIAGNOSTIC%20AID%20IN%20CERTAIN%20TYPES%20OF%20PRIMARY%20ATYPICAL%20PNEUMONIA&amp;rft.jtitle=Journal%20of%20the%20American%20Medical%20Association&amp;rft.stitle=Journal%20of%20the%20American%20Medical%20Association&amp;rft.volume=122&amp;rft.issue=6&amp;rft.aufirst=Dorothy%20M.&amp;rft.aulast=Horstmann&amp;rft.au=Dorothy%20M.%20Horstmann&amp;rft.au=Hugh%20Tatlock&amp;rft.date=1943-06-05&amp;rft.pages=369-370&amp;rft.spage=369&amp;rft.epage=370&amp;rft.issn=0002-9955"></span>
  <div class="csl-entry">Ito, S., Wang, D., Purcell, A., Chetlapalli, K., Lee, A. I., Cuker, A., &amp; Goshua, G. (2023). Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States. <i>Blood</i>, <i>142</i>(Supplement 1), 2316. <a href="https://doi.org/10.1182/blood-2023-187270">https://doi.org/10.1182/blood-2023-187270</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2023-187270&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cost-Effectiveness%20of%20Sutimlimab%20Versus%20Standard-of-Care%20in%20Transfusion%20Dependent%20Patients%20with%20Primary%20Cold%20Agglutinin%20Disease%20in%20the%20United%20States&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=142&amp;rft.issue=Supplement%201&amp;rft.aufirst=Satoko&amp;rft.aulast=Ito&amp;rft.au=Satoko%20Ito&amp;rft.au=Daniel%20Wang&amp;rft.au=Adriana%20Purcell&amp;rft.au=Karthik%20Chetlapalli&amp;rft.au=Alfred%20I%20Lee&amp;rft.au=Adam%20Cuker&amp;rft.au=George%20Goshua&amp;rft.date=2023-11-28&amp;rft.pages=2316&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Jacobs, J. W., Booth, G. S., Woo, J. S., Adkins, B. D., &amp; Stephens, L. D. (2024). How the United States syphilis epidemic may portend a resurgence of an unusual hematologic condition: The connection between syphilis and paroxysmal cold hemoglobinuria. <i>American Journal of Hematology</i>, <i>99</i>(3), 484–485. <a href="https://doi.org/10.1002/ajh.27190">https://doi.org/10.1002/ajh.27190</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1002%2Fajh.27190&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=How%20the%20United%20States%20syphilis%20epidemic%20may%20portend%20a%20resurgence%20of%20an%20unusual%20hematologic%20condition%3A%20The%20connection%20between%20syphilis%20and%20paroxysmal%20cold%20hemoglobinuria&amp;rft.jtitle=American%20Journal%20of%20Hematology&amp;rft.volume=99&amp;rft.issue=3&amp;rft.aufirst=Jeremy%20W.&amp;rft.aulast=Jacobs&amp;rft.au=Jeremy%20W.%20Jacobs&amp;rft.au=Garrett%20S.%20Booth&amp;rft.au=Jennifer%20S.%20Woo&amp;rft.au=Brian%20D.%20Adkins&amp;rft.au=Laura%20D.%20Stephens&amp;rft.date=2024&amp;rft.pages=484-485&amp;rft.spage=484&amp;rft.epage=485&amp;rft.issn=1096-8652"></span>
  <div class="csl-entry">Jäger, U., D’Sa, S., Schörgenhofer, C., Bartko, J., Derhaschnig, U., Sillaber, C., Jilma-Stohlawetz, P., Fillitz, M., Schenk, T., Patou, G., Panicker, S., Parry, G. C., Gilbert, J. C., &amp; Jilma, B. (2019). Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: A first-in-human trial. <i>Blood</i>, <i>133</i>(9), 893–901. <a href="https://doi.org/10.1182/blood-2018-06-856930">https://doi.org/10.1182/blood-2018-06-856930</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2018-06-856930&amp;rft_id=info%3Apmid%2F30559259&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Inhibition%20of%20complement%20C1s%20improves%20severe%20hemolytic%20anemia%20in%20cold%20agglutinin%20disease%3A%20a%20first-in-human%20trial&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=133&amp;rft.issue=9&amp;rft.aufirst=Ulrich&amp;rft.aulast=J%C3%A4ger&amp;rft.au=Ulrich%20J%C3%A4ger&amp;rft.au=Shirley%20D'Sa&amp;rft.au=Christian%20Sch%C3%B6rgenhofer&amp;rft.au=Johann%20Bartko&amp;rft.au=Ulla%20Derhaschnig&amp;rft.au=Christian%20Sillaber&amp;rft.au=Petra%20Jilma-Stohlawetz&amp;rft.au=Michael%20Fillitz&amp;rft.au=Thomas%20Schenk&amp;rft.au=Gary%20Patou&amp;rft.au=Sandip%20Panicker&amp;rft.au=Graham%20C.%20Parry&amp;rft.au=James%20C.%20Gilbert&amp;rft.au=Bernd%20Jilma&amp;rft.date=2019-02-28&amp;rft.pages=893-901&amp;rft.spage=893&amp;rft.epage=901&amp;rft.issn=1528-0020&amp;rft.language=eng"></span>
  <div class="csl-entry">Jain, M. D., Cabrerizo-Sanchez, R., Karkouti, K., Yau, T., Pendergrast, J. M., &amp; Cserti-Gazdewich, C. M. (2013). Seek and you shall find--but then what do you do? Cold agglutinins in cardiopulmonary bypass and a single-center experience with cold agglutinin screening before cardiac surgery. <i>Transfusion Medicine Reviews</i>, <i>27</i>(2), 65–73. <a href="https://doi.org/10.1016/j.tmrv.2012.12.001">https://doi.org/10.1016/j.tmrv.2012.12.001</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tmrv.2012.12.001&amp;rft_id=info%3Apmid%2F23375735&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seek%20and%20you%20shall%20find--but%20then%20what%20do%20you%20do%3F%20Cold%20agglutinins%20in%20cardiopulmonary%20bypass%20and%20a%20single-center%20experience%20with%20cold%20agglutinin%20screening%20before%20cardiac%20surgery&amp;rft.jtitle=Transfusion%20Medicine%20Reviews&amp;rft.stitle=Transfus%20Med%20Rev&amp;rft.volume=27&amp;rft.issue=2&amp;rft.aufirst=Michael%20D.&amp;rft.aulast=Jain&amp;rft.au=Michael%20D.%20Jain&amp;rft.au=Rosa%20Cabrerizo-Sanchez&amp;rft.au=Keyvan%20Karkouti&amp;rft.au=Terrence%20Yau&amp;rft.au=Jacob%20M.%20Pendergrast&amp;rft.au=Christine%20M.%20Cserti-Gazdewich&amp;rft.date=2013-04&amp;rft.pages=65-73&amp;rft.spage=65&amp;rft.epage=73&amp;rft.issn=1532-9496&amp;rft.language=eng"></span>
  <div class="csl-entry">Kanthack, A. A., Durham, H. E., &amp; Blandford, W. F. H. (1898). On Nagana, or Tsetse Fly Disease. (Report, Made to the Tsetse Fly Committee of the Royal Society, of Observations and Experiments Carried out from November, 1896, to August, 1898). <i>Proceedings of the Royal Society of London</i>, <i>64</i>, 100–118.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=On%20Nagana%2C%20or%20Tsetse%20Fly%20Disease.%20(Report%2C%20Made%20to%20the%20Tsetse%20Fly%20Committee%20of%20the%20Royal%20Society%2C%20of%20Observations%20and%20Experiments%20Carried%20out%20from%20November%2C%201896%2C%20to%20August%2C%201898)&amp;rft.jtitle=Proceedings%20of%20the%20Royal%20Society%20of%20London&amp;rft.volume=64&amp;rft.aufirst=A.%20A.&amp;rft.aulast=Kanthack&amp;rft.au=A.%20A.%20Kanthack&amp;rft.au=H.%20E.%20Durham&amp;rft.au=W.%20F.%20H.%20Blandford&amp;rft.date=1898&amp;rft.pages=100-118&amp;rft.spage=100&amp;rft.epage=118&amp;rft.issn=0370-1662"></span>
  <div class="csl-entry">Khwaja, J., Japzon, N., Gabriel, M., Raju, K., Rajaratnam, V., Gupta, R., Rismani, A., Kyriakou, C., &amp; D’Sa, S. (2024). Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact. <i>British Journal of Haematology</i>, <i>204</i>(2), e21–e24. <a href="https://doi.org/10.1111/bjh.19185">https://doi.org/10.1111/bjh.19185</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.19185&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cold%20agglutinin%20disease%20and%20cryoglobulinaemia%3A%20A%20frequent%20coexistence%20with%20clinical%20impact&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.volume=204&amp;rft.issue=2&amp;rft.aufirst=Jahanzaib&amp;rft.aulast=Khwaja&amp;rft.au=Jahanzaib%20Khwaja&amp;rft.au=Nicole%20Japzon&amp;rft.au=Maria%20Gabriel&amp;rft.au=Kavin%20Raju&amp;rft.au=Vijith%20Rajaratnam&amp;rft.au=Rajeev%20Gupta&amp;rft.au=Ali%20Rismani&amp;rft.au=Chara%20Kyriakou&amp;rft.au=Shirley%20D'Sa&amp;rft.date=2024&amp;rft.pages=e21-e24&amp;rft.spage=e21&amp;rft.epage=e24&amp;rft.issn=1365-2141&amp;rft.language=en"></span>

</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Landsteiner, K. (1903). Über Beziehungen zwischen dem Blutserum und den Körperzellen. <i>Münchener medizinische Wochenschrift</i>, <i>50</i>, 1812–1814.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%C3%9Cber%20Beziehungen%20zwischen%20dem%20Blutserum%20und%20den%20K%C3%B6rperzellen&amp;rft.jtitle=M%C3%BCnchener%20medizinische%20Wochenschrift&amp;rft.stitle=M%C3%BCnch%20Med%20Wschr&amp;rft.volume=50&amp;rft.aufirst=Karl&amp;rft.aulast=Landsteiner&amp;rft.au=Karl%20Landsteiner&amp;rft.date=1903&amp;rft.pages=1812-1814&amp;rft.spage=1812&amp;rft.epage=1814&amp;rft.language=German"></span>
  <div class="csl-entry">Lee, E. J., &amp; Kueck, B. (1998). Rituxan in the Treatment of Cold Agglutinin Disease. <i>Blood</i>, <i>92</i>(9), 3490–3491. <a href="https://doi.org/10.1182/blood.V92.9.3490">https://doi.org/10.1182/blood.V92.9.3490</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V92.9.3490&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rituxan%20in%20the%20Treatment%20of%20Cold%20Agglutinin%20Disease&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=92&amp;rft.issue=9&amp;rft.aufirst=Edward%20J.&amp;rft.aulast=Lee&amp;rft.au=Edward%20J.%20Lee&amp;rft.au=Brian%20Kueck&amp;rft.date=1998-11-01&amp;rft.pages=3490-3491&amp;rft.spage=3490&amp;rft.epage=3491&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">LUBINSKI, H., &amp; GOLDBLOOM, A. (1946). ACUTE HEMOLYTIC ANEMIA ASSOCIATED WITH AUTOAGGLUTINATION WITH A THERMAL AMPLITUDE OF 0 TO 37 C. <i>American Journal of Diseases of Children</i>, <i>72</i>(3), 325–333. <a href="https://doi.org/10.1001/archpedi.1946.02020320076009">https://doi.org/10.1001/archpedi.1946.02020320076009</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1001%2Farchpedi.1946.02020320076009&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ACUTE%20HEMOLYTIC%20ANEMIA%20ASSOCIATED%20WITH%20AUTOAGGLUTINATION%20WITH%20A%20THERMAL%20AMPLITUDE%20OF%200%20TO%2037%20C.&amp;rft.jtitle=American%20Journal%20of%20Diseases%20of%20Children&amp;rft.stitle=American%20Journal%20of%20Diseases%20of%20Children&amp;rft.volume=72&amp;rft.issue=3&amp;rft.aufirst=HERBERT&amp;rft.aulast=LUBINSKI&amp;rft.au=HERBERT%20LUBINSKI&amp;rft.au=ALTON%20GOLDBLOOM&amp;rft.date=1946-09-01&amp;rft.pages=325-333&amp;rft.spage=325&amp;rft.epage=333&amp;rft.issn=0096-8994"></span>
  <div class="csl-entry">Mbaya, A., Kumshe, H., &amp; Okwudiri, C. (2012). The Mechanisms of Anaemia in Trypanosomosis: A Review. In D. Silverberg (Ed.), <i>Anemia</i>. InTech. <a href="https://doi.org/10.5772/29530">https://doi.org/10.5772/29530</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=urn%3Aisbn%3A978-953-51-0138-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=The%20Mechanisms%20of%20Anaemia%20in%20Trypanosomosis%3A%20A%20Review&amp;rft.publisher=InTech&amp;rft.aufirst=Albert&amp;rft.aulast=Mbaya&amp;rft.au=Donald%20Silverberg&amp;rft.au=Albert%20Mbaya&amp;rft.au=Hussein%20Kumshe&amp;rft.au=Chukwunyere%20Okwudiri&amp;rft.date=2012-02-29&amp;rft.isbn=978-953-51-0138-3&amp;rft.language=en"></span>
  <div class="csl-entry">McCOMBS, R. P., &amp; McELROY, J. S. (1937). REVERSIBLE AUTOHEMAGGLUTINATION WITH PERIPHERAL VASCULAR SYMPTOMS. <i>Archives of Internal Medicine</i>, <i>59</i>(1), 107–117. <a href="https://doi.org/10.1001/archinte.1937.00170170113007">https://doi.org/10.1001/archinte.1937.00170170113007</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.1937.00170170113007&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=REVERSIBLE%20AUTOHEMAGGLUTINATION%20WITH%20PERIPHERAL%20VASCULAR%20SYMPTOMS&amp;rft.jtitle=Archives%20of%20Internal%20Medicine&amp;rft.stitle=Archives%20of%20Internal%20Medicine&amp;rft.volume=59&amp;rft.issue=1&amp;rft.aufirst=ROBERT%20P.&amp;rft.aulast=McCOMBS&amp;rft.au=ROBERT%20P.%20McCOMBS&amp;rft.au=JAMES%20S.%20McELROY&amp;rft.date=1937-01-01&amp;rft.pages=107-117&amp;rft.spage=107&amp;rft.epage=117&amp;rft.issn=0730-188X"></span>
  <div class="csl-entry">Nelson, R. (2023). Syphilis rates soar in the USA amid penicillin shortage. <i>The Lancet</i>, <i>402</i>(10401), 515. <a href="https://doi.org/10.1016/S0140-6736(23)01665-3">https://doi.org/10.1016/S0140-6736(23)01665-3</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736(23)01665-3&amp;rft_id=info%3Apmid%2F37573855&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Syphilis%20rates%20soar%20in%20the%20USA%20amid%20penicillin%20shortage&amp;rft.jtitle=The%20Lancet&amp;rft.stitle=The%20Lancet&amp;rft.volume=402&amp;rft.issue=10401&amp;rft.aufirst=Roxanne&amp;rft.aulast=Nelson&amp;rft.au=Roxanne%20Nelson&amp;rft.date=2023-08-12&amp;rft.pages=515&amp;rft.issn=0140-6736%2C%201474-547X&amp;rft.language=English"></span>
  <div class="csl-entry">Olesen, H. (1964). CHLORAMBUCIL TREATMENT IN THE COLD AGGLUTININ SYNDROME. <i>Scandinavian Journal of Haematology</i>, <i>1</i>, 116–128. <a href="https://doi.org/10.1111/j.1600-0609.1964.tb00010.x">https://doi.org/10.1111/j.1600-0609.1964.tb00010.x</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0609.1964.tb00010.x&amp;rft_id=info%3Apmid%2F14184545&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=CHLORAMBUCIL%20TREATMENT%20IN%20THE%20COLD%20AGGLUTININ%20SYNDROME&amp;rft.jtitle=Scandinavian%20Journal%20of%20Haematology&amp;rft.stitle=Scand%20J%20Haematol&amp;rft.volume=1&amp;rft.aufirst=H.&amp;rft.aulast=Olesen&amp;rft.au=H.%20Olesen&amp;rft.date=1964&amp;rft.pages=116-128&amp;rft.spage=116&amp;rft.epage=128&amp;rft.issn=0036-553X&amp;rft.language=eng"></span>
  <div class="csl-entry">Rossi, G., Gramegna, D., Paoloni, F., Fattizzo, B., Binda, F., D’Adda, M., Farina, M., Lucchini, E., Mauro, F. R., Salvi, F., Marchetti, M., Fazi, P., Zaja, F., &amp; Barcellini, W. (2018). Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: A phase 2 prospective GIMEMA study. <i>Blood</i>, <i>132</i>(5), 547–550. <a href="https://doi.org/10.1182/blood-2018-03-835413">https://doi.org/10.1182/blood-2018-03-835413</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2018-03-835413&amp;rft_id=info%3Apmid%2F29898955&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Short%20course%20of%20bortezomib%20in%20anemic%20patients%20with%20relapsed%20cold%20agglutinin%20disease%3A%20a%20phase%202%20prospective%20GIMEMA%20study&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=132&amp;rft.issue=5&amp;rft.aufirst=Giuseppe&amp;rft.aulast=Rossi&amp;rft.au=Giuseppe%20Rossi&amp;rft.au=Doriana%20Gramegna&amp;rft.au=Francesca%20Paoloni&amp;rft.au=Bruno%20Fattizzo&amp;rft.au=Francesca%20Binda&amp;rft.au=Mariella%20D'Adda&amp;rft.au=Mirko%20Farina&amp;rft.au=Elisa%20Lucchini&amp;rft.au=Francesca%20Romana%20Mauro&amp;rft.au=Flavia%20Salvi&amp;rft.au=Monia%20Marchetti&amp;rft.au=Paola%20Fazi&amp;rft.au=Francesco%20Zaja&amp;rft.au=Wilma%20Barcellini&amp;rft.date=2018-08-02&amp;rft.pages=547-550&amp;rft.spage=547&amp;rft.epage=550&amp;rft.issn=1528-0020&amp;rft.language=eng"></span>

</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Röth, A., Barcellini, W., D’Sa, S., Miyakawa, Y., Broome, C. M., Michel, M., Kuter, D. J., Jilma, B., Tvedt, T. H. A., Fruebis, J., Jiang, X., Lin, S., Reuter, C., Morales-Arias, J., Hobbs, W., &amp; Berentsen, S. (2021). Sutimlimab in Cold Agglutinin Disease. <i>New England Journal of Medicine</i>, <i>384</i>(14), 1323–1334. <a href="https://doi.org/10.1056/NEJMoa2027760">https://doi.org/10.1056/NEJMoa2027760</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2027760&amp;rft_id=info%3Apmid%2F33826820&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sutimlimab%20in%20Cold%20Agglutinin%20Disease&amp;rft.jtitle=New%20England%20Journal%20of%20Medicine&amp;rft.volume=384&amp;rft.issue=14&amp;rft.aufirst=Alexander&amp;rft.aulast=R%C3%B6th&amp;rft.au=Alexander%20R%C3%B6th&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Shirley%20D%E2%80%99Sa&amp;rft.au=Yoshitaka%20Miyakawa&amp;rft.au=Catherine%20M.%20Broome&amp;rft.au=Marc%20Michel&amp;rft.au=David%20J.%20Kuter&amp;rft.au=Bernd%20Jilma&amp;rft.au=Tor%20H.A.%20Tvedt&amp;rft.au=Joachim%20Fruebis&amp;rft.au=Xiaoyu%20Jiang&amp;rft.au=Stella%20Lin&amp;rft.au=Caroline%20Reuter&amp;rft.au=Jaime%20Morales-Arias&amp;rft.au=William%20Hobbs&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.date=2021-04-08&amp;rft.pages=1323-1334&amp;rft.spage=1323&amp;rft.epage=1334&amp;rft.issn=0028-4793"></span>
  <div class="csl-entry">Röth, A., Barcellini, W., D’Sa, S., Miyakawa, Y., Broome, C. M., Michel, M., Kuter, D. J., Jilma, B., Tvedt, T. H. A., Weitz, I. C., Yoo, R., Jayawardene, D., Vagge, D. S., Kralova, K., Shafer, F., Wardȩcki, M., Lee, M., &amp; Berentsen, S. (2023). Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. <i>American Journal of Hematology</i>, <i>98</i>(8), 1246–1253. <a href="https://doi.org/10.1002/ajh.26965">https://doi.org/10.1002/ajh.26965</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1002%2Fajh.26965&amp;rft_id=info%3Apmid%2F37246953&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sustained%20inhibition%20of%20complement%20C1s%20with%20sutimlimab%20over%202%E2%80%89years%20in%20patients%20with%20cold%20agglutinin%20disease&amp;rft.jtitle=American%20Journal%20of%20Hematology&amp;rft.stitle=Am%20J%20Hematol&amp;rft.volume=98&amp;rft.issue=8&amp;rft.aufirst=Alexander&amp;rft.aulast=R%C3%B6th&amp;rft.au=Alexander%20R%C3%B6th&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Shirley%20D'Sa&amp;rft.au=Yoshitaka%20Miyakawa&amp;rft.au=Catherine%20M.%20Broome&amp;rft.au=Marc%20Michel&amp;rft.au=David%20J.%20Kuter&amp;rft.au=Bernd%20Jilma&amp;rft.au=Tor%20Henrik%20Anderson%20Tvedt&amp;rft.au=Ilene%20C.%20Weitz&amp;rft.au=Ronnie%20Yoo&amp;rft.au=Deepthi%20Jayawardene&amp;rft.au=Deepthi%20S.%20Vagge&amp;rft.au=Katarina%20Kralova&amp;rft.au=Frank%20Shafer&amp;rft.au=Marek%20Ward%C8%A9cki&amp;rft.au=Michelle%20Lee&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.date=2023-08&amp;rft.pages=1246-1253&amp;rft.spage=1246&amp;rft.epage=1253&amp;rft.issn=1096-8652&amp;rft.language=eng"></span>
  <div class="csl-entry">Röth, A., Barcellini, W., Tvedt, T. H. A., Miyakawa, Y., Kuter, D. J., Su, J., Jiang, X., Hobbs, W., Arias, J. M., Shafer, F., &amp; Weitz, I. C. (2022). Sutimlimab improves quality of life in patients with cold agglutinin disease: Results of patient-reported outcomes from the CARDINAL study. <i>Annals of Hematology</i>, <i>101</i>(10), 2169–2177. <a href="https://doi.org/10.1007/s00277-022-04948-y">https://doi.org/10.1007/s00277-022-04948-y</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1007%2Fs00277-022-04948-y&amp;rft_id=info%3Apmid%2F35999387&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sutimlimab%20improves%20quality%20of%20life%20in%20patients%20with%20cold%20agglutinin%20disease%3A%20results%20of%20patient-reported%20outcomes%20from%20the%20CARDINAL%20study&amp;rft.jtitle=Annals%20of%20Hematology&amp;rft.stitle=Ann%20Hematol&amp;rft.volume=101&amp;rft.issue=10&amp;rft.aufirst=Alexander&amp;rft.aulast=R%C3%B6th&amp;rft.au=Alexander%20R%C3%B6th&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Tor%20Henrik%20Anderson%20Tvedt&amp;rft.au=Yoshitaka%20Miyakawa&amp;rft.au=David%20J.%20Kuter&amp;rft.au=Jun%20Su&amp;rft.au=Xiaoyu%20Jiang&amp;rft.au=William%20Hobbs&amp;rft.au=Jaime%20Morales%20Arias&amp;rft.au=Frank%20Shafer&amp;rft.au=Ilene%20C.%20Weitz&amp;rft.date=2022-10&amp;rft.pages=2169-2177&amp;rft.spage=2169&amp;rft.epage=2177&amp;rft.issn=1432-0584&amp;rft.language=eng"></span>
  <div class="csl-entry">Röth, A., Berentsen, S., Barcellini, W., D’Sa, S., Jilma, B., Michel, M., Weitz, I. C., Yamaguchi, M., Nishimura, J., Vos, J. M. I., Storek, M., Wong, N., Patel, P., Jiang, X., Vagge, D. S., Wardęcki, M., Shafer, F., Lee, M., &amp; Broome, C. M. (2022). Sutimlimab in patients with cold agglutinin disease: Results of the randomized placebo-controlled phase 3 CADENZA trial. <i>Blood</i>, <i>140</i>(9), 980–991. <a href="https://doi.org/10.1182/blood.2021014955">https://doi.org/10.1182/blood.2021014955</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.2021014955&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sutimlimab%20in%20patients%20with%20cold%20agglutinin%20disease%3A%20results%20of%20the%20randomized%20placebo-controlled%20phase%203%20CADENZA%20trial&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=140&amp;rft.issue=9&amp;rft.aufirst=Alexander&amp;rft.aulast=R%C3%B6th&amp;rft.au=Alexander%20R%C3%B6th&amp;rft.au=Sigbj%C3%B8rn%20Berentsen&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Shirley%20D%E2%80%99Sa&amp;rft.au=Bernd%20Jilma&amp;rft.au=Marc%20Michel&amp;rft.au=Ilene%20C.%20Weitz&amp;rft.au=Masaki%20Yamaguchi&amp;rft.au=Jun-ichi%20Nishimura&amp;rft.au=Josephine%20M.%20I.%20Vos&amp;rft.au=Michael%20Storek&amp;rft.au=Nancy%20Wong&amp;rft.au=Parija%20Patel&amp;rft.au=Xiaoyu%20Jiang&amp;rft.au=Deepthi%20S.%20Vagge&amp;rft.au=Marek%20Ward%C4%99cki&amp;rft.au=Frank%20Shafer&amp;rft.au=Michelle%20Lee&amp;rft.au=Catherine%20M.%20Broome&amp;rft.date=2022-09-01&amp;rft.pages=980-991&amp;rft.spage=980&amp;rft.epage=991&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Röth, A., Broome, C. M., Barcellini, W., Tvedt, T. H. A., Miyakawa, Y., D’Sa, S., Cella, D., Bozzi, S., Jayawardene, D., Yoo, R., Shafer, F., Wardęcki, M., &amp; Weitz, I. C. (2023). Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. <i>Blood Advances</i>, <i>7</i>(19), 5890–5897. <a href="https://doi.org/10.1182/bloodadvances.2022009318">https://doi.org/10.1182/bloodadvances.2022009318</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fbloodadvances.2022009318&amp;rft_id=info%3Apmid%2F37459203&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term%20sutimlimab%20improves%20quality%20of%20life%20for%20patients%20with%20cold%20agglutinin%20disease%3A%20CARDINAL%202-year%20follow-up&amp;rft.jtitle=Blood%20Advances&amp;rft.stitle=Blood%20Adv&amp;rft.volume=7&amp;rft.issue=19&amp;rft.aufirst=Alexander&amp;rft.aulast=R%C3%B6th&amp;rft.au=Alexander%20R%C3%B6th&amp;rft.au=Catherine%20M.%20Broome&amp;rft.au=Wilma%20Barcellini&amp;rft.au=Tor%20Henrik%20Anderson%20Tvedt&amp;rft.au=Yoshitaka%20Miyakawa&amp;rft.au=Shirley%20D'Sa&amp;rft.au=David%20Cella&amp;rft.au=Sylvie%20Bozzi&amp;rft.au=Deepthi%20Jayawardene&amp;rft.au=Ronnie%20Yoo&amp;rft.au=Frank%20Shafer&amp;rft.au=Marek%20Ward%C4%99cki&amp;rft.au=Ilene%20C.%20Weitz&amp;rft.date=2023-10-10&amp;rft.pages=5890-5897&amp;rft.spage=5890&amp;rft.epage=5897&amp;rft.issn=2473-9537&amp;rft.language=eng"></span>
  <div class="csl-entry">Ruzickova, S., Pruss, A., Odendahl, M., Wolbart, K., Burmester, G.-R., Scholze, J., Dörner, T., &amp; Hansen, A. (2002). Chronic lymphocytic leukemia preceded by cold agglutinin disease: Intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells. <i>Blood</i>, <i>100</i>(9), 3419–3422. <a href="https://doi.org/10.1182/blood.V100.9.3419">https://doi.org/10.1182/blood.V100.9.3419</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V100.9.3419&amp;rft_id=info%3Apmid%2F12384446&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chronic%20lymphocytic%20leukemia%20preceded%20by%20cold%20agglutinin%20disease%3A%20intraclonal%20immunoglobulin%20light-chain%20diversity%20in%20V(H)4-34%20expressing%20single%20leukemic%20B%20cells&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=100&amp;rft.issue=9&amp;rft.aufirst=Sarka&amp;rft.aulast=Ruzickova&amp;rft.au=Sarka%20Ruzickova&amp;rft.au=Axel%20Pruss&amp;rft.au=Marcus%20Odendahl&amp;rft.au=Karsten%20Wolbart&amp;rft.au=Gerd-R%C3%BCdiger%20Burmester&amp;rft.au=J%C3%BCrgen%20Scholze&amp;rft.au=Thomas%20D%C3%B6rner&amp;rft.au=Arne%20Hansen&amp;rft.date=2002-11-01&amp;rft.pages=3419-3422&amp;rft.spage=3419&amp;rft.epage=3422&amp;rft.issn=0006-4971&amp;rft.language=eng"></span>

</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">

  <div class="csl-entry">Schubothe, H. (1966). The cold hemagglutinin disease. <i>Seminars in Hematology</i>, <i>3</i>(1), 27–47.</div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Apmid%2F5323366&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The%20cold%20hemagglutinin%20disease&amp;rft.jtitle=Seminars%20in%20Hematology&amp;rft.stitle=Semin%20Hematol&amp;rft.volume=3&amp;rft.issue=1&amp;rft.aufirst=H.&amp;rft.aulast=Schubothe&amp;rft.au=H.%20Schubothe&amp;rft.date=1966-01&amp;rft.pages=27-47&amp;rft.spage=27&amp;rft.epage=47&amp;rft.issn=0037-1963&amp;rft.language=eng"></span>
  <div class="csl-entry">Steverding, D. (2008). The history of African trypanosomiasis. <i>Parasites &amp; Vectors</i>, <i>1</i>, 3. <a href="https://doi.org/10.1186/1756-3305-1-3">https://doi.org/10.1186/1756-3305-1-3</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1186%2F1756-3305-1-3&amp;rft_id=info%3Apmid%2F18275594&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The%20history%20of%20African%20trypanosomiasis&amp;rft.jtitle=Parasites%20%26%20Vectors&amp;rft.stitle=Parasit%20Vectors&amp;rft.volume=1&amp;rft.aufirst=Dietmar&amp;rft.aulast=Steverding&amp;rft.au=Dietmar%20Steverding&amp;rft.date=2008-02-12&amp;rft.pages=3&amp;rft.issn=1756-3305"></span>
  <div class="csl-entry">Swiecicki, P. L., Hegerova, L. T., &amp; Gertz, M. A. (2013). Cold agglutinin disease. <i>Blood</i>, <i>122</i>(7), 1114–1121. <a href="https://doi.org/10.1182/blood-2013-02-474437">https://doi.org/10.1182/blood-2013-02-474437</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2013-02-474437&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cold%20agglutinin%20disease&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=122&amp;rft.issue=7&amp;rft.aufirst=Paul%20L.&amp;rft.aulast=Swiecicki&amp;rft.au=Paul%20L.%20Swiecicki&amp;rft.au=Livia%20T.%20Hegerova&amp;rft.au=Morie%20A.%20Gertz&amp;rft.date=2013-08-15&amp;rft.pages=1114-1121&amp;rft.spage=1114&amp;rft.epage=1121&amp;rft.issn=0006-4971"></span>

</div>
